• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    5/5/25 9:00:20 AM ET
    $ISRG
    Industrial Specialties
    Health Care
    Get the next $ISRG alert in real time by email
    isrg-20250501
    0001035267false00010352672025-05-052025-05-05

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of
    The Securities Exchange Act of 1934
      Date of Report (Date of earliest event reported): May 1, 2025
    INTUITIVE SURGICAL, INC.
    (Exact name of registrant as specified in its charter)
    Delaware  000-30713  77-0416458
    (State or other jurisdiction
    of incorporation)
      (Commission File Number)  (I.R.S. Employer Identification No.)
    1020 Kifer Road
    Sunnyvale, California 94086
    (Address of principal executive offices) (zip code)
       Registrant’s telephone number, including area code: (408) 523-2100
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common Stock, par value $0.001 per share ISRG The Nasdaq Global Select Market
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨  





    Item 5.02.
    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
    Approval of the Amendment and Restatement of the Amended and Restated 2010 Incentive Award Plan
    The Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) previously adopted, subject to stockholder approval, the amendment and restatement of the Company’s Amended and Restated 2010 Incentive Award Plan (the “Amended 2010 Plan”), which (i) increases the number of shares of common stock reserved for issuance pursuant to awards granted under the Amended 2010 Plan from 115,350,000 to 120,350,000, (ii) extends the term of the Amended 2010 Plan to January 30, 2035, and (iii) further specifies the treatment of awards in connection with a change in control. At the Company’s annual meeting of stockholders held on May 1, 2025 (the “Annual Meeting”), the Company’s stockholders approved the Amended 2010 Plan. The foregoing description of the Amended 2010 Plan is qualified in its entirety by reference to the text of the Amended 2010 Plan, which is filed as Exhibit 10.1 hereto and incorporated herein by reference.
    Item 5.07.Submission of Matters to a Vote of Security Holders.
    At the Annual Meeting, the stockholders of Intuitive Surgical, Inc. (the “Company”) voted on the following six proposals, each of which is described in detail in the Proxy Statement filed with the Securities and Exchange Commission on March 14, 2025.
    Proposal No. 1: To elect eleven members to the Board to serve until the 2026 Annual Meeting of Stockholders:
    NomineeForAgainstAbstainBroker Non-votes
    Craig H. Barratt, Ph.D.282,752,8857,233,9241,634,67827,776,231
    Joseph C. Beery289,980,911654,739985,83727,776,231
    Lewis Chew
    288,387,9212,250,733982,83327,776,231
    Gary S. Guthart, Ph.D.289,603,0271,057,211961,24927,776,231
    Amal M. Johnson274,984,60015,528,9591,107,92827,776,231
    Sreelakshmi Kolli
    287,387,6683,013,9731,219,84627,776,231
    Amy L. Ladd, M.D.290,098,720551,292971,47527,776,231
    Keith R. Leonard, Jr. 282,603,6448,034,335983,50827,776,231
    Jami Dover Nachtsheim289,668,912973,871978,70427,776,231
    Monica P. Reed, M.D.290,055,318591,611974,55827,776,231
    David J. Rosa286,640,6774,019,744961,06627,776,231
    Each of the nominees nominated in Proposal No. 1 was elected.
    Proposal No. 2: To consider and approve, on an advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the Proxy Statement:
    ForAgainstAbstainBroker Non-votes
    273,643,15517,266,578711,75427,776,231
    Proposal No. 2 was approved on an advisory basis.
    Proposal No. 3: To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025:
    ForAgainstAbstain
    315,779,3433,268,278350,097
    Proposal No. 3 was approved.
    Proposal No. 4: To approve the amendment and restatement of the Company’s Amended and Restated 2010 Incentive Award Plan:
    ForAgainstAbstainBroker Non-votes
    260,242,21030,524,920854,35727,776,231
    Proposal No. 4 was approved.



    Proposal No. 5: To consider and vote upon a stockholder proposal purportedly “to improve the executive compensation program”:
    ForAgainstAbstainBroker Non-votes
    13,158,332276,529,2311,933,92427,776,231
    Proposal No. 5 was rejected.
    Proposal No. 6: To consider and vote upon a stockholder proposal that is titled “Shareholder approval requirement for excessive golden parachutes”:
    ForAgainstAbstainBroker Non-votes
    128,529,042161,977,7631,114,68227,776,231
    Proposal No. 6 was rejected.
    Item 7.01.
    Regulation FD Disclosure.
    On May 1, 2025, the Board of Directors of the Company increased the authorized amount available under the Company’s common stock repurchase program (the “Repurchase Program”) to an aggregate of $4.0 billion, including amounts remaining under previous authorization.
    The timing and total amount of repurchases will depend upon market conditions and may be made from time to time in open market purchases, privately negotiated transactions, accelerated share repurchase programs, issuer self-tender offers or otherwise, as determined by the Company’s management. The repurchases will be made in compliance with, and at such times as permitted by, federal securities law and may be suspended or discontinued at any time. The Repurchase Program does not obligate the Company to acquire any particular amount of common stock. The Company expects to fund the Repurchase Program through cash, cash equivalents, and investments.
    Forward-Looking Statements
    This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to expectations concerning matters that are not historical facts. Statements using words such as “estimates,” “projects,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “may,” “will,” “could,” “should,” “would,” “targeted,” and similar words and expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to the following: statements regarding the potential repurchase by the Company of up to $4.0 billion of its common stock and the timing and form of stock repurchase transactions; and the source of funds used for such repurchases. These forward-looking statements are necessarily estimates reflecting the judgment of the Company’s management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should be considered in light of various important factors, including, but not limited to, the following: the overall macroeconomic environment, which may impact customer spending and the Company’s costs, including tariffs, the levels of inflation, and interest rates; the conflict between Ukraine and Russia; conflicts in the Middle East; disruption to the Company’s supply chain, including difficulties in obtaining a sufficient supply of materials; curtailed or delayed capital spending by hospitals; and the impact of global and regional economic and credit market conditions on healthcare spending. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report and which are based on current expectations and are subject to risks, uncertainties, and assumptions that are difficult to predict, including those risk factors identified under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as updated by the Company’s other filings with the Securities and Exchange Commission. The Company’s actual results may differ materially and adversely from those expressed in any forward-looking statement, and the Company undertakes no obligation to publicly update or release any revisions to these forward-looking statements, except as required by law.



    Item 9.01.Financial Statements and Exhibits.
    (d) Exhibits.
    Exhibit NumberDescription
    10.1
    Intuitive Surgical, Inc. Amended and Restated 2010 Incentive Award Plan, as amended and restated.
    104Cover Page Interactive Data File (embedded within the Inline XBRL document).



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    INTUITIVE SURGICAL, INC.
    Date: May 5, 2025By:/s/ JAMIE E. SAMATH
         Name: Jamie E. Samath
    Title: Executive Vice President, Chief Financial Officer

    Get the next $ISRG alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ISRG

    DatePrice TargetRatingAnalyst
    6/9/2025$440.00Hold → Sell
    Deutsche Bank
    6/5/2025Hold → Buy
    Erste Group
    12/2/2024$522.00 → $650.00Equal-Weight → Overweight
    Morgan Stanley
    8/2/2024$380.00 → $510.00Neutral → Buy
    Redburn Atlantic
    7/10/2024$462.00 → $512.00Buy
    Citigroup
    5/30/2024$500.00Buy
    Goldman
    11/17/2023$318.00Buy
    HSBC Securities
    7/19/2023$377.00Outperform
    Robert W. Baird
    More analyst ratings

    $ISRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Intuitive Surgical downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded Intuitive Surgical from Hold to Sell and set a new price target of $440.00

      6/9/25 7:47:07 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical upgraded by Erste Group

      Erste Group upgraded Intuitive Surgical from Hold to Buy

      6/5/25 7:52:11 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded Intuitive Surgical from Equal-Weight to Overweight and set a new price target of $650.00 from $522.00 previously

      12/2/24 6:57:53 AM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Chief Executive Officer (CEO) Rosa David J.

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      7/11/25 4:55:47 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • President Rosa David J. converted options into 1,358 shares and covered exercise/tax liability with 674 shares, increasing direct ownership by 0.30% to 231,756 units (SEC Form 4)

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      6/10/25 12:36:53 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SVP & Chief Mfg and Supply Cha Brosius Mark sold $242,182 worth of shares (431 units at $561.91), decreasing direct ownership by 32% to 907 units (SEC Form 4)

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      6/6/25 4:20:59 PM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    SEC Filings

    See more
    • SEC Form 144 filed by Intuitive Surgical Inc.

      144 - INTUITIVE SURGICAL INC (0001035267) (Subject)

      6/10/25 4:01:41 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

      5/15/25 9:05:20 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

      5/5/25 9:00:20 AM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Vessel Sealer Curved receives FDA clearance

      SUNNYVALE, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food & Drug Administration (FDA) has cleared its latest innovation in advanced energy instrumentation for use with its multiport da Vinci systems. Vessel Sealer Curved is a fully wristed, advanced bipolar electrosurgical instrument designed to seal, cut, grasp, and dissect tissue. It is the first of Intuitive's advanced energy instruments to receive FDA clearance for the transection of lymphatic vessels. Vessel Sealer Curved offers enhanced multifunctionality and precision via its sli

      7/10/25 9:15:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive's da Vinci 5 Surgical System Receives CE Mark

      SUNNYVALE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the da Vinci 5 Surgical System has received CE mark approval for adult and pediatric use in Europe for minimally invasive endoscopic procedures across abdominopelvic and thoracoscopic surgical procedures, including urologic, gynecologic, and general laparoscopic procedures. Da Vinci 5 is Intuitive's most advanced and integrated multiport robotic-assisted surgical system, building on the da Vinci Xi Surgical System's highly functional design. It features more than 150 enhancements and joins a

      7/2/25 9:46:50 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • 30 years of Innovation and Impact: Dan Larson's Inspiring Story

      SUNNYVALE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- When Seattle resident Dan Larson was diagnosed with lung cancer in 2023, his only exposure to robotic technology was through his work as a quality engineer at Boeing. He could never have imagined that robotic technology made by Intuitive, the pioneer of robotic-assisted surgery, would one day play a pivotal role in his health care. Having experienced the loss of his father to lung cancer, Dan was determined to overcome his own diagnosis and enjoy his retirement with his family. Under the care of clinicians at MultiCare Tacoma General Hospital in Washington, Dan underwent two robotic lung biopsies with the Ion Endoluminal System, Intuit

      5/27/25 9:15:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Leadership Updates

    Live Leadership Updates

    See more
    • 30 years of Innovation and Impact: Dan Larson's Inspiring Story

      SUNNYVALE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- When Seattle resident Dan Larson was diagnosed with lung cancer in 2023, his only exposure to robotic technology was through his work as a quality engineer at Boeing. He could never have imagined that robotic technology made by Intuitive, the pioneer of robotic-assisted surgery, would one day play a pivotal role in his health care. Having experienced the loss of his father to lung cancer, Dan was determined to overcome his own diagnosis and enjoy his retirement with his family. Under the care of clinicians at MultiCare Tacoma General Hospital in Washington, Dan underwent two robotic lung biopsies with the Ion Endoluminal System, Intuit

      5/27/25 9:15:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces CEO Transition Effective July 1, 2025

      President Dave Rosa promoted to CEOCurrent CEO Gary Guthart to become executive chair of Intuitive's boardCurrent Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer, effective July 1, 2025. At that time, current CEO Gary Guthart will become the executive chair of Intuitive's board of directors, and current Board Chair Craig Barratt will become lead independent director. Guthart will work closely with Rosa to support a smooth t

      5/15/25 9:05:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

      3/7/25 6:19:00 PM ET
      $ALK
      $AMBC
      $ATI
      $BBWI
      Air Freight/Delivery Services
      Consumer Discretionary
      Property-Casualty Insurers
      Finance

    $ISRG
    Financials

    Live finance-specific insights

    See more
    • Intuitive Announces First Quarter Earnings

      SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2025. Q1 Highlights Worldwide da Vinci procedures grew approximately 17% compared with the first quarter of 2024.The Company placed 367 da Vinci surgical systems, compared with 313 in the first quarter of 2024. The first quarter 2025 da Vinci surgical system placements included 147 da Vinci 5 systems, compared with 8 in the first quarter of 2024.The Company grew its da Vinci surgical system installed base to 10,189 systems as of Mar

      4/22/25 4:05:00 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces Fourth Quarter Earnings

      SUNNYVALE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2024. Q4 Highlights Worldwide da Vinci procedures grew approximately 18% compared with the fourth quarter of 2023.The Company placed 493 da Vinci surgical systems, compared with 415 in the fourth quarter of 2023. The fourth quarter 2024 da Vinci surgical system placements included 174 da Vinci 5 systems.The Company grew its da Vinci surgical system installed base to 9,902 systems as of December 31, 2024, an increase of 15%

      1/23/25 4:05:00 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces Preliminary Fourth Quarter and Full Year 2024 Results

      SUNNYVALE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2024 financial results ahead of its presentation at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025. Financial and Operational Highlights Fourth quarter 2024 worldwide da Vinci procedures grew approximately 18% compared with the fourth quarter of 2023.Full year 2024 worldwide da Vinci procedures grew approximately 17% compared with 2023. The Company expects worldwide da Vinci procedures to i

      1/15/25 9:00:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

      SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

      2/14/24 10:02:59 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

      SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

      2/14/23 12:37:59 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

      SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

      2/9/23 11:22:22 AM ET
      $ISRG
      Industrial Specialties
      Health Care